Q-omics provides the consensus-scored MIR5688 profile across patient tissues and cancer cell-line models. MIR5688 expression is associated with patient survival in 9 of 34 cancer types, with the highest sampling consensus in KIRC. Among the 18 cancer types available for tumor–normal comparison, MIR5688 is differentially expressed in 1, with the highest sampling consensus in THCA. Additionally, MIR5688 RNA expression shows 9,920 significant gene co-expression associations, with the highest sampling consensus in LUSC. Together, these results highlight KIRC, THCA, and LUSC as cancer lineages where MIR5688 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for MIR5688 — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes MIR5688 survival associations across molecular data types. MIR5688 RNA expression shows survival associations in the most cancer types (9). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible MIR5688 RNA expression–survival associations across cancer types. High MIR5688 expression shows unfavorable associations in KIRC, PAAD, UCS, ACC and SARC, but favorable associations in BLCA. The KIRC Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p = .006). Together, the overview and detailed table identify KIRC as the clearest survival context for MIR5688 RNA expression.
This table summarizes MIR5688 tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 1. The strongest signals are observed in THCA for RNA.
This table ranks reproducible tumor–normal expression differences for MIR5688. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. MIR5688 shows lower tumor expression in THCA. The THCA box plot shows higher MIR5688 RNA expression in normal versus tumor tissue (log2 FC = −0.117, t-test p = .007).
This table shows molecular features associated with MIR5688 in patient tissues and cancer cell lines. In patient samples, MIR5688 shows the broadest associations at the RNA and protein expression levels, with LUSC recurring as the lineage with the largest associated feature set.
